SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bonello Michael J.

(Last)

(First)

(Middle)

C/O PRA HEALTH SCIENCES, INC.

4130 PARKLAKE AVENUE, SUITE 400

(Street)

RALEIGH

27612

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2018

3. Issuer Name and Ticker or Trading Symbol
PRA Health Sciences, Inc. [ PRAH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Exec VP & CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	18,000⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	12/20/2023	Common Stock	20,736	$11.73	D
Stock Option (Right to Buy)	⁽³⁾	12/20/2023	Common Stock	12,636	$11.73	D
Stock Option (Right to Buy)	⁽⁴⁾	08/29/2027	Common Stock	20,000	$75.81	D
Stock Option (Right to Buy)	⁽⁵⁾	04/26/2028	Common Stock	80,000	$81.61	D

Explanation of Responses:

1. Represents shares of restricted stock granted on April 26, 2018 under the issuer's 2014 Omnibus Incentive Plan (the "2014 Plan"), of which two-thirds will vest on the second anniversary of the grant date and the remaining one-third will vest on the third anniversary of the grant date, subject to the holder's continued service through such dates.

2. The options were granted on December 20, 2013 under the issuer's 2013 Stock Incentive Plan (the "2013 Plan"). 3,681 options vested on September 23, 2016, 8,527 options vested on September 23, 2017, and the remaining 8,528 options will vest on September 23, 2018, subject to the holder's continued service through such date.

3. The options were granted on December 20, 2013 under the 2013 Plan. The options vested on November 16, 2016, based on the achievement of specified performance targets.

4. The options were granted on August 29, 2017 under the 2014 Plan and vest as follows: (a) 20% on each of August 29, 2018 and August 29, 2019 and (b) 30% on each of August 29, 2020 and August 29, 2021, subject to the holder's continued service through such dates.

5. The options were granted on April 26, 2018 under the 2014 Plan and vest 25% each year starting on the first anniversary of the grant date, subject to the holder's continued service through such dates.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Timothy J. McClain, by power of attorney	05/01/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.